DODGE Jeffrey A.
No ORCID on file
· 168 papers in corpus
· active 1995-2007
Frequent coauthors
- BRYANT Henry U. 136
- FAHEY Kennan J. 32
- JONES Charles D. 32
- CULLINAN GEORGE J 24
- LUGAR Charles W. 16
- FRANK SCOTT A 16
- HUMMEL CONRAD W 16
- WALLACE OWEN B 8
- DALLY ROBERT D 8
- FONG KIN C 8
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
2006
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2006
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2006
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2006
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2006
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2006
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2006
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2006
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2004
The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);Ris -H, -OH, -O(C1-C4 alkyl)…
2004
The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);Ris -H, -OH, -O(C1-C4 alkyl)…
2004
The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);Ris -H, -OH, -O(C1-C4 alkyl)…
2004
The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);Ris -H, -OH, -O(C1-C4 alkyl)…
2004
The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);Ris -H, -OH, -O(C1-C4 alkyl)…
2004
The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);Ris -H, -OH, -O(C1-C4 alkyl)…
2004
The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);Ris -H, -OH, -O(C1-C4 alkyl)…
2004
The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);Ris -H, -OH, -O(C1-C4 alkyl)…
2002
The present invention provides method of treating endometriosis using novel benzothiophene compounds of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(…